Aclaris Therapeutics Inc (NASDAQ:ACRS)
| 1.06 Delayed Data As of Apr 01 |  +0.02 / +1.92%Today’s Change | 0.70 Today|||52-Week Range 7.15 | -43.92% Year-to-Date |
Latest ACRS News | Press Releases
No recent news for Aclaris Therapeutics Inc.
Today’s Trading
| Previous close | 1.04 |
| Today’s open | 0.96 |
| Day’s range | 0.96 - 1.07 |
| Volume | 8,920 |
| Average volume (3 months) | 622,183 |
| Market cap | $46.1M |
Data as of 4:00pm ET, 04/01/2020
Growth & Valuation
| Earnings growth (last year) | +3.19% |
| Earnings growth (this year) | +64.23% |
| Earnings growth (next 5 years) | +38.60% |
| Revenue growth (last year) | -58.11% |
| P/E ratio | NM |
| Price/Sales | 18.48 |
| Price/Book | 0.66 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NNVCNanoViricides Inc | -0.20 | -3.40% |
| MDWDMediwound Ltd | -0.07 | -4.46% |
| ACORAcorda Therapeutics ... | -0.13 | -14.34% |
| ONCTOncternal Therapeuti... | +0.08 | +2.73% |
Data as of 4:00pm ET, 04/01/2020
Financials
| Next reporting date | May 6, 2020 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $4.2M |
| Annual profit (last year) | -$161.4M |
| Net profit margin | -2,686.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Malvern, Pennsylvania |
Forecasts
